These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24134796)

  • 1. Translating pharmacogenomics discoveries into the clinic: an implementation framework.
    Huang RS; Gamazon ER
    Genome Med; 2013; 5(10):94. PubMed ID: 24134796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Coriell personalized medicine collaborative pharmacogenomics appraisal, evidence scoring and interpretation system.
    Gharani N; Keller MA; Stack CB; Hodges LM; Schmidlen TJ; Lynch DE; Gordon ES; Christman MF
    Genome Med; 2013; 5(10):93. PubMed ID: 24134832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice.
    Squassina A; Manchia M; Manolopoulos VG; Artac M; Lappa-Manakou C; Karkabouna S; Mitropoulos K; Del Zompo M; Patrinos GP
    Pharmacogenomics; 2010 Aug; 11(8):1149-67. PubMed ID: 20712531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics and individualized medicine: translating science into practice.
    Crews KR; Hicks JK; Pui CH; Relling MV; Evans WE
    Clin Pharmacol Ther; 2012 Oct; 92(4):467-75. PubMed ID: 22948889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translating genomic discoveries to the clinic in pediatric oncology.
    Glade Bender J; Verma A; Schiffman JD
    Curr Opin Pediatr; 2015 Feb; 27(1):34-43. PubMed ID: 25502895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translating pharmacogenomics: challenges on the road to the clinic.
    Swen JJ; Huizinga TW; Gelderblom H; de Vries EG; Assendelft WJ; Kirchheiner J; Guchelaar HJ
    PLoS Med; 2007 Aug; 4(8):e209. PubMed ID: 17696640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Success stories in genomic medicine from resource-limited countries.
    Mitropoulos K; Al Jaibeji H; Forero DA; Laissue P; Wonkam A; Lopez-Correa C; Mohamed Z; Chantratita W; Lee MT; Llerena A; Brand A; Ali BR; Patrinos GP
    Hum Genomics; 2015 Jun; 9(1):11. PubMed ID: 26081768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics--how close/far are we to practising individualized medicine for children?
    Sing CW; Cheung CL; Wong IC
    Br J Clin Pharmacol; 2015 Mar; 79(3):419-28. PubMed ID: 25855823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of a multidisciplinary pharmacogenomics clinic in a community health system.
    Dunnenberger HM; Biszewski M; Bell GC; Sereika A; May H; Johnson SG; Hulick PJ; Khandekar J
    Am J Health Syst Pharm; 2016 Dec; 73(23):1956-1966. PubMed ID: 27864203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NAVAGATE: a rubric to move from pharmacogenomics science to pharmacogenomics practice.
    Roederer MW
    Pharmacogenomics; 2012 Aug; 13(11):1307-13. PubMed ID: 22920399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translating pharmacogenomics into personalized medicine and drug development.
    Zhang W; Chan TY; Fan L; Guo Y; Zhou HH
    Per Med; 2012 Jan; 9(1):93-97. PubMed ID: 29783288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adoption of Pharmacogenomic Testing: A Marketing Perspective.
    Koufaki MI; Karamperis K; Vitsa P; Vasileiou K; Patrinos GP; Mitropoulou C
    Front Pharmacol; 2021; 12():724311. PubMed ID: 34603034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Knowledge-based System for Intelligent Support in Pharmacogenomics Evidence Assessment: Ontology-driven Evidence Representation and Retrieval.
    Lee CJ; Devine B; Tarczy-Hornoch P
    AMIA Jt Summits Transl Sci Proc; 2017; 2017():175-184. PubMed ID: 28815127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare payers: a gate or translational bridge to personalized medicine?
    Canestaro WJ; Martell LA; Wassman ER; Schatzberg R
    Per Med; 2012 Jan; 9(1):73-84. PubMed ID: 29783295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of hospital pharmacists in the adoption and use of pharmacogenomics and precision medicine.
    Schwartz EJ; Issa AM
    Per Med; 2017 Jan; 14(1):27-35. PubMed ID: 29749827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. personalized medicine and pharmacogenomics: ethical and social challenges.
    Lee SS
    Per Med; 2005 Mar; 2(1):29-35. PubMed ID: 29793238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating pharmacogenomics into pharmacy practice via medication therapy management.
    Reiss SM;
    J Am Pharm Assoc (2003); 2011; 51(6):e64-74. PubMed ID: 22001957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation.
    Sipeky C; Llerena A; Manolopoulos VG; Pearson E; Mlakar V; Gozzo L; Simmaco M; Marchetti P; Re MD; Stankovic S; Meyer U; Cascorbi I; Ingelman-Sundberg M; Suarez-Kurtz G; Marc J; Katsila T; Paulmichl M; Nofziger C; Ansari M; Drago F; van Schaik RH
    Pharmacogenomics; 2019 Oct; 20(15):1063-1069. PubMed ID: 31588876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of pharmacogenomics into the clinical practice of therapeutics: issues for the clinician and the laboratorian.
    Wu AH; Babic N; Yeo KJ
    Per Med; 2009 May; 6(3):315-327. PubMed ID: 29783510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translating Knowledge from Research to Outcomes: Pharmacogenomics in the Treatment of HIV/AIDS.
    Hewitt JE
    J Law Med; 2016; 24(1):166-80. PubMed ID: 30136780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.